STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Stocks
News - Investor Relations | STADA
Press release: STADA sustains strong momentum with double-digit sales and profit ... | Presseportal
STADA Arzneimittel: Driving growth with a culture that puts people first
Nidda Healthcare GmbH - Investor Relations
IR Contact - Investor Relations | STADA
Annual General Meeting 2020 - Investor Relations | STADA
Annual Report 2022 | STADA
Press release: Zuellig Pharma becomes STADA Philippines' exclusive distribution partner | Presseportal
STADA's excellent results in H1 2023 | STADA
Financial Reports - Investor Relations | STADA
News - Investor Relations | STADA
STADA and Alvotech broaden European patients' options by launching Hukyndra® high-concentration, citrate-free adalimumab - Alvotech
STADA_Press Conference_Invitation_2023.pdf | STADA Arzneimittel AG
Annual Report 2022 | STADA
Hemofarm - News - STADA Health Report 2023: Mental Health of Europeans Is Improving
Financial Reports - Investor Relations | STADA
Financial Reports - Investor Relations | STADA
News - Investor Relations | STADA
Hemofarm - News - STADA Health Report: 81 percent of Europeans are open towards genetic testing
News - Investor Relations | STADA
Farmaceutica: il Gruppo STADA continua a crescere anche in tempi difficili
Hemofarm - News - STADA's 2021 above-market development strengthens base for further growth, especially in Consumer Healthcare and Specialty
Financial Reports - Investor Relations | STADA
